US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Unicredit Spa (CRIN) 銘柄情報

Unicredit Spa (CRIN)

81.86

1.62

(2.02%)

終了 7月10日 5:00AM

Unicredit Spa (CRIN) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

81.86

( 2.02% )

買値

81.78

売値

81.93

出来高

9,492

平均取引量 (3 か月)

5,896,560 €

財務取引量

-

80.39 日の範囲 82.07

0.00 52 週間の範囲 0.00

時価総額

企業価値

-

前日終値

80.24

始値

80.39

時刻

最終取引時間

VWAP

-

歳入

25.46B

純利益

11.36B

発行済株式数

1,498,277,375

浮動株比率 (%)

99.81%

機関投資家保有比率 (%)

43.36%

配当利回り

3.15 (4.47%)

PER

11.29

株価売上高倍率 (PSR)

4.82

1 株当たり利益 (EPS)

7.26

ベータ

1.06

UniCredit S.p.A. provides commercial banking services in Italy, Germany, Central Europe, and Eastern Europe. The company offers retail, private, and wealth management solutions; and institutional investor solutions. It also provides corporate finance advisory, rating advisory, financial sponsor, pat... UniCredit S.p.A. provides commercial banking services in Italy, Germany, Central Europe, and Eastern Europe. The company offers retail, private, and wealth management solutions; and institutional investor solutions. It also provides corporate finance advisory, rating advisory, financial sponsor, patient capital, capital structure advisory, and sustainable finance solutions, as well as securities services. In addition, the company offers transactional and risk management, structured finance, debt funding, equity funding, project finance, commodity trade finance, and trade and export finance services; group trade and correspondent banking services; and payments solutions. It serves SME, corporate, multinational corporate, financial institution, and public sector clients, as well as retail, private banking, wealth management, and family office clients. UniCredit S.p.A. was founded in 1870 and is headquartered in Milan, Italy. 詳細を表示

セクター

Finance

業界

Banking

ウェブサイト

www.unicreditgroup.eu

本社

Milan, Italy

設立

1870

Unicredit Spa is listed in the Finance sector of the Tradegate (DE) with ticker CRIN. The last closing price for Unicredit was 80.24 €. Over the last year, Unicredit shares have traded in a share price range of 0.00 € to 0.00 €.

Unicredit currently has 1,498,277,375 shares in issue. The market capitalisation of Unicredit is 122.65 € billion. Unicredit has a price to earnings ratio (PE ratio) of 11.29.

Übernahmeangebot / Zielgesellschaft: COMMERZBANK Aktiengesellschaft; Bieter: UniCredit S.p.A.

UniCredit S.p.A. / Übernahmeangebot Übernahmeangebot / Zielgesellschaft: COMMERZBANK Aktiengesellschaft; Bieter: UniCredit S.p.A. 16.03.2026 /...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

CRIN - Frequently Asked Questions (FAQ)

What is the current Unicredit Spa share price?

The current share price of Unicredit Spa is 81.86 €

How many Unicredit Spa shares are in issue?

Unicredit Spa has 1,498,277,375 shares in issue

What is the market cap of Unicredit Spa?

The market capitalisation of Unicredit Spa is EUR 122.65B

What is the 1 year trading range for Unicredit Spa share price?

Unicredit Spa has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Unicredit Spa?

The price to earnings ratio of Unicredit Spa is 11.29

What is the cash to sales ratio of Unicredit Spa?

The cash to sales ratio of Unicredit Spa is 4.82

What is the registered address of Unicredit Spa?

The registered address for Unicredit Spa is Tower A, Milan, Milan, 20154

What is the Unicredit Spa website address?

The website address for Unicredit Spa is www.unicreditgroup.eu

Which industry sector does Unicredit Spa operate in?

Unicredit Spa operates in the Banking sector

88TH MAN

88TH MAN 4分前

Holding all my shares. BULLISH!!!

DJknows

DJknows 4分前

I was supposed to quit for the night with the last post but thought I'd check out Mr. Taylor's LinkedIn and found the following:

https://www.linkedin.com/in/rodolfo-taylor-07b32791/recent-activity/all/

Rodolfo Taylor
Automotive Professional Consultant. Sp

ghostandgurgi

ghostandgurgi 5分前

Even 1-100 split only gets this to $3 and they need $4 to uplist, so not sure how they plan to get there.

johnydollar

johnydollar 5分前

Sometimes i wonder how old some people are...........

Online........

Am sure some do have snot running down their nose.......

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆

Hey_Its_That_Guy

Hey_Its_That_Guy 7分前

Because you touch yourself at night

biotech_researcher

biotech_researcher 10分前

Well, most of have reached the 3.5 year point from our last shot, so we can be confident that the vaccine has cleared. What’s the point of this article?

johnydollar

johnydollar 10分前

For a minute there i thought about lucky Gilmore..........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹

Jetmek_03052

Jetmek_03052 11分前

88TH MAN

88TH MAN 11分前

Buy, buy, buy... Hold, hold, hold... Profit, profit, profit. BULLISH!!!

Porch Honkey

Porch Honkey 12分前

Nonsense, lol. Craig Marshak holds the Wertheim trademark name and sits on your company's board as a private director of that company, per se, lmao!

samson8

samson8 13分前

500 million more shares added today

88TH MAN

88TH MAN 14分前

Charles Schwab shows $0.10. The chart on E*Trade shows $0.10. I am convinced $0.10 is the true price. I had an order to Sell at $0.10. At this point, I will not sell for less than $0.10. BULLISH!!!

SkiMan85

SkiMan85 15分前

I think GetRch$lwly laid out a reasonable “everything goes perfectly” scenario, but I still think it’s probably too optimistic.

NAMSA absolutely improves the odds of getting the IDE right the first time, but it doesn’t eliminate FDA review timelines or potential questions. They still

DrivenByPain

DrivenByPain 16分前

🤑SNTX🤑 You All Ready To See A Million + In Your Accounts $🤑$🤑$🤑$🤑$🤑$🤑$🤑Elon Be Liking Mr Leal !

KeepItRealistic

KeepItRealistic 19分前

$OSRH what is there not to like 💎
- $815 million funding for advancing their drug VAXIM while looking for a big pharmaceutical partner during that process.
- $15 million in funding starting in October at $10 a share
- a NDA with a 8 billion in sales company to investiga

KeepItRealistic

KeepItRealistic 19分前

$OSRH what is there not to like 💎
- $815 million funding for advancing their drug VAXIM while looking for a big pharmaceutical partner during that process.
- $15 million in funding starting in October at $10 a share
- a NDA with a 8 billion in sales company to investiga

Kentucky123

Kentucky123 20分前

I know most do not follow charts and think they are useless for low cap bio. They have been right for the last five years. In order for that to change I believe we need to see volume of 10 million shares on big news. Here is the chart.
https://schrts.co/mHVrctPW

hankmanhub

hankmanhub 20分前

• “…recognizing the impact this medicine could potentially have.”
This could be true of every single treatment that is up for approval, as a new treatment not yet available prior to approval,

Guido2

Guido2 28分前

https://x.com/GuidoPerei/status/2075395630298804549?s=20

DJknows

DJknows 29分前

One new comment on today's The Luminary Live program from Rodolfo Taylor:

https://www.linkedin.com/in/robertblum/recent-activity/comments/

Rodolfo Taylor
Automotive Professional Consultant. Specializing in Next-Gen Mobility, Advancing the Transition from Copper t

Guido2

Guido2 29分前

https://x.com/GuidoPerei/status/2075395630298804549?s=20

US Market News

US Market News 30分前

Australian Firms Shift Cybersecurity Focus to ResilienceJuly 9, 2026 9:43 PM
Business Wire Organizations seek partners with local capabilities, including AI risk management and regulatory readiness, ISG Provider Lens® report says Enterprises

Goats'nCrows

Goats'nCrows 32分前

barnstormer, are you okay? Marnix Bosch is one person. Not being facetious, do you feel okay?

Momentum_Scalper

Momentum_Scalper 32分前

Definitely getting the feeling these guys took the summer off. Hopefully not the case.

Rani Therapeutics

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。